Search Results for: Respiratory

2697 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
CDC42 and RAC2 cell division cycle 42 Rac family small GTPase 2
  • GPVI-mediated activation cascade
  • EGFR downregulation
  • Rho GTPase cycle
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • CD28 dependent Vav1 pathway
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • DCC mediated attractive signaling
  • Inactivation of CDC42 and RAC1
  • VEGFA-VEGFR2 Pathway
  • Myogenesis
  • Myogenesis
  • RHO GTPases activate KTN1
  • RHO GTPases activate IQGAPs
  • RHO GTPases activate PAKs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate Formins
  • RHO GTPases Activate Formins
  • MAPK6/MAPK4 signaling
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • G beta:gamma signalling through CDC42
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • GPVI-mediated activation cascade
  • ROS and RNS production in phagocytes
  • PIP3 activates AKT signaling
  • Rho GTPase cycle
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • PCP/CE pathway
  • RHO GTPases Activate NADPH Oxidases
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Aminophosphonic Acid-Guanylate Ester
  • Guanosine-5'-Diphosphate
  • Dextromethorphan
  • Leukocyte adhesion deficiency (LAD), including the following four diseases: Leukocyte adhesion deficiency (I); Leukocyte adhesion deficiency (II); Leukocyte adhesion deficiency (III); LAD with Rac2 deficiency
CDH2 and GRIN1 cadherin 2 glutamate ionotropic receptor NMDA type subunit 1
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Adherens junctions interactions
  • Myogenesis
  • Myogenesis
  • Post-translational protein phosphorylation
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • RAF/MAP kinase cascade
  • Neurexins and neuroligins
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Glutamic Acid
  • Atomoxetine
  • Pentobarbital
  • Secobarbital
  • Pethidine
  • Acamprosate
  • Gabapentin
  • Memantine
  • Orphenadrine
  • Phenobarbital
  • Prasterone
  • Dcka, 5,7-Dichlorokynurenic Acid
  • D-Serine
  • Cycloleucine
  • Milnacipran
  • CNS-5161
  • Acetylcysteine
  • Ketobemidone
  • Gavestinel
  • Agmatine
  • Ifenprodil
  • Magnesium acetate tetrahydrate
  • Magnesium carbonate
  • Fluciclovine (18F)
CDH2 and CDH4 cadherin 2 cadherin 4
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Adherens junctions interactions
  • Myogenesis
  • Myogenesis
  • Post-translational protein phosphorylation
  • Adherens junctions interactions
  • Myogenesis
  • Myogenesis
CDH4 and MTNR1B cadherin 4 melatonin receptor 1B
  • Adherens junctions interactions
  • Myogenesis
  • Myogenesis
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (i) signalling events
  • Ramelteon
  • Melatonin
  • Resveratrol
  • Agomelatine
  • Tasimelteon
  • Type II diabetes mellitus
CDH4 and UBE2I cadherin 4 ubiquitin conjugating enzyme E2 I
  • Adherens junctions interactions
  • Myogenesis
  • Myogenesis
  • Meiotic synapsis
  • Vitamin D (calciferol) metabolism
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMOylation of DNA damage response and repair proteins
  • SUMO E3 ligases SUMOylate target proteins
  • SUMOylation of transcription factors
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of chromatin organization proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of DNA methylation proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Processing of DNA double-strand break ends
  • Formation of Incision Complex in GG-NER
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Postmitotic nuclear pore complex (NPC) reformation
CDK6 and PPARGC1A cyclin dependent kinase 6 PPARG coactivator 1 alpha
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Cyclin D associated events in G1
  • Regulation of RUNX1 Expression and Activity
  • Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
  • Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • SUMOylation of transcription cofactors
  • Circadian Clock
  • Circadian Clock
  • Regulation of RUNX2 expression and activity
  • Regulation of RUNX2 expression and activity
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Alvocidib
  • (2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol
  • 3,7,3',4'-TETRAHYDROXYFLAVONE
  • Palbociclib
  • Ribociclib
  • Abemaciclib
CDK9 and GRN cyclin dependent kinase 9 granulin precursor
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • Interactions of Tat with host cellular proteins
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase II Transcription Elongation
  • Estrogen-dependent gene expression
  • Neutrophil degranulation
  • Alvocidib
  • Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
CDKN1B and YWHAZ cyclin dependent kinase inhibitor 1B tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
  • SCF(Skp2)-mediated degradation of p27/p21
  • AKT phosphorylates targets in the cytosol
  • Senescence-Associated Secretory Phenotype (SASP)
  • DNA Damage/Telomere Stress Induced Senescence
  • RHO GTPases activate CIT
  • Constitutive Signaling by AKT1 E17K in Cancer
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • Cyclin D associated events in G1
  • p53-Dependent G1 DNA Damage Response
  • Cyclin A:Cdk2-associated events at S phase entry
  • PTK6 Regulates Cell Cycle
  • FOXO-mediated transcription of cell cycle genes
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Deactivation of the beta-catenin transactivating complex
  • Rap1 signalling
  • GP1b-IX-V activation signalling
  • KSRP (KHSRP) binds and destabilizes mRNA
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • NOTCH4 Activation and Transmission of Signal to the Nucleus
  • Negative regulation of NOTCH4 signaling
  • Regulation of localization of FOXO transcription factors
  • Phenethyl Isothiocyanate
  • Prostate cancer
CDKN1C and NR4A2 cyclin dependent kinase inhibitor 1C nuclear receptor subfamily 4 group A member 2
  • Cyclin D associated events in G1
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Beckwith-Wiedemann syndrome
  • Adrenal carcinoma
  • Parkinson's disease (PD)
CDKN2D and NR4A2 cyclin dependent kinase inhibitor 2D nuclear receptor subfamily 4 group A member 2
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Cyclin D associated events in G1
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Parkinson's disease (PD)
CDR2 and NDN cerebellar degeneration related protein 2 necdin, MAGE family member
  • Interleukin-4 and Interleukin-13 signaling
  • Prader-Willi and Angelman syndromes, including: Angelman syndrome (AS); Prader-Willi syndrome (PWS)
CDX4 and HOXA5 caudal type homeobox 4 homeobox A5
CEACAM5 and UQCC2 CEA cell adhesion molecule 5 ubiquinol-cytochrome c reductase complex assembly factor 2
  • Post-translational modification: synthesis of GPI-anchored proteins
  • Cell surface interactions at the vascular wall
  • S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate
CENPE and TRAF4 centromere protein E TNF receptor associated factor 4
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • RHO GTPases Activate Formins
  • COPI-dependent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • EML4 and NUDC in mitotic spindle formation
  • Kinesins
  • GSK-923295
CETN3 and LMNA centrin 3 lamin A/C
  • XBP1(S) activates chaperone genes
  • Signaling by BRAF and RAF fusions
  • Restrictive dermopathy
  • Emery-Dreifuss muscular dystrophy
  • Dilated cardiomyopathy (DCM)
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Mandibuloacral dysplasia
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
  • Limb-girdle muscular dystrophy (LGMD)
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Hutchinson-Gilford progeria syndrome
CFL1 and YWHAZ cofilin 1 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
  • Platelet degranulation
  • Regulation of actin dynamics for phagocytic cup formation
  • EPHB-mediated forward signaling
  • Sema3A PAK dependent Axon repulsion
  • RHO GTPases Activate ROCKs
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Deactivation of the beta-catenin transactivating complex
  • Rap1 signalling
  • GP1b-IX-V activation signalling
  • KSRP (KHSRP) binds and destabilizes mRNA
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • NOTCH4 Activation and Transmission of Signal to the Nucleus
  • Negative regulation of NOTCH4 signaling
  • Regulation of localization of FOXO transcription factors
  • Lauryl Dimethylamine-N-Oxide
  • Copper
  • Artenimol
  • Phenethyl Isothiocyanate
CGB3 and NLGN3 chorionic gonadotropin subunit beta 3 neuroligin 3
  • Glycoprotein hormones
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Neurexins and neuroligins
  • Neurexins and neuroligins
CHGB and TAZ chromogranin B tafazzin
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Mitochondrial protein import
  • Mitochondrial protein import
  • Acyl chain remodeling of CL
  • 3-Methylglutaconic aciduria (MGCA)
  • Barth syndrome (BTHS)
  • Dilated cardiomyopathy (DCM)
CHGB and RAC2 chromogranin B Rac family small GTPase 2
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • GPVI-mediated activation cascade
  • ROS and RNS production in phagocytes
  • PIP3 activates AKT signaling
  • Rho GTPase cycle
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • PCP/CE pathway
  • RHO GTPases Activate NADPH Oxidases
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Dextromethorphan
  • Leukocyte adhesion deficiency (LAD), including the following four diseases: Leukocyte adhesion deficiency (I); Leukocyte adhesion deficiency (II); Leukocyte adhesion deficiency (III); LAD with Rac2 deficiency
CHM and RAB3A CHM Rab escort protein RAB3A, member RAS oncogene family
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • GABA synthesis, release, reuptake and degradation
  • Choroideremia (CHM); Tapetochoroidal dystrophy

Page 36 out of 135 pages